Systemic Chemotherapy, Lenvatinib Plus Sintilimab for ICC With Distant Metastasis
Clinical trial NCT04769908 · UNKNOWN
Trial details
- NCT number
- NCT04769908
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-23
- Primary completion
- 2021-12-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.